ACR Convergence Virtual

American College of Rheumatology (ACR) Convergence 2020, the world’s premier virtual rheumatology experience, is offering stellar rheumatology education and outstanding networking opportunities.

Posters will be displayed from November 4, 2020 to March 11, 2021. Attendees can live chat with Carelon Research’s presenting authors from 9:00 to 11:00 AM ET November 6, 7, and 8. Registration is required to view posters/recorded presentations.

Carelon Research presentations

Carelon Research authors are indicated in bold.

Presentation	Session	Title	Authors	Affiliations
Friday, November 6, 2020 Live chat with Dr. Michael Grabner 9:00 AM – 11:00 AM ET	Poster Session A Spondyloarthritis including psoriatic arthritis – treatment poster I	0371 \| Identifying Inadequate Response Among Ankylosing Spondylitis Patients Prescribed Biologics in a Real-world Commercially Insured Adult Population in the United States	Hunter T¹, Grabner M², Isenberg K³, Shan M⁴, Teng CC², Lisse J⁴, Curtis JR5	¹Eli Lilly and Company, Indianapolis; ²Carelon Research, Wilmington, DE; ³Elevance Health, Indianapolis, IN; ⁴Eli Lilly and Company, Indianapolis, IN; ⁵Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Saturday, November 7, 2020 Live chat with Dr. Michael Grabner 9:00 AM – 11:00 AM ET	Poster Session B Spondyloarthritis including psoriatic arthritis – treatment poster II	0898 \| Inadequate Response among Psoriatic Arthritis Patients Prescribed Advanced Therapy in a Real-world US Commercially Insured Population	Birt J¹, Grabner M², Isenberg K³, Hunter T⁴, Teng CC², Shan M¹, Lisse J¹, Wu J¹, Griffing K¹, Curtis JR⁵	¹Eli Lilly and Company, Indianapolis, IN; ²Carelon Research, Wilmington, DE; ³Elevance Health, Indianapolis, IN; ⁴Eli Lilly and Company, Indianapolis; ⁵Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Friday, November 6, 2020 Live chat with Dr. Michael Grabner 9:00 AM – 11:00 AM ET	Poster Session C Epidemiology & public health poster III: inflammatory rheumatic disease	1030 \| Pain Medication Use among Ankylosing Spondylitis and Psoriatic Arthritis Patients Before and After Initiation of Biologic Therapy	Hunter T¹, Nguyen C², Birt J³, Smith J², Shan M³, Tan H², Lisse J³, Isenberg K⁴	¹Eli Lilly and Company, Indianapolis; ²Carelon Research, Wilmington, DE; ³Eli Lilly and Company, Indianapolis, IN; ⁴Elevance Health, Indianapolis, IN

Carelon Research presentations

Ready to learn more? Let's connect.